Chapter 10 – Neonatal Complications: ROP, BPD, and NEC

Retinopathy of Prematurity (ROP)

Definition and Overview

Retinopathy of Prematurity is an aberrant, pathologic development of retinal blood vessels in premature infants. It can culminate in complete and irreversible blindness if progression is unchecked.

Epidemiology and Risk Profile

• Prematurity itself – and thus incomplete in-utero vascularization – is the single greatest risk.
• Oxygen plays a critical modulatory role in post-natal vascular growth.
  • Approximately $66\%$ of infants with a birth weight $\le 1250\ \text{g}$ develop some degree of ROP.
  • Among those $\le 750\ \text{g}$, incidence climbs to $90\%$.

Etiology

Excessive supplemental $O_2$ is the most consistently implicated external trigger.

Pathophysiology

• Normal retinal vascularization ordinarily finishes between the $35^{\text{th}}$ and $44^{\text{th}}$ gestational week.
• Pre-term infants must complete vascularization in a comparatively hyperoxic ex-utero milieu.
• Systemic insults ‎— sepsis, compromised perfusion, necrotizing enterocolitis, intraventricular hemorrhage ‎— delay physiologic proliferation.

Biphasic Disease Model

1. Primary (vaso-obliterative) phase – typically noted around $31$ weeks’ post-menstrual age; characterized by arrest or regression of normal vascular advance.
2. Secondary (neovascular) phase – requires adequate levels of VEGF and IGF-1 within the still-avascular retina.
   • VEGF is up-regulated in response to relative hypoxia.
   • Excessive, disordered proliferation produces a vascular “ridge,” dilated tortuous vessels, and may extend into the vitreous. Without intervention, the sequence progresses to traction, detachment, and blindness.

Classification – International Classification of ROP (ICROP)

• Anatomical zone: $\text{Zone }1$ (posterior pole) through $\text{Zone }3$ (peripheral).
• Severity staging:
  • Stage 1 – thin demarcation line between vascular and avascular retina.
  • Stage 2 – line acquires height/width (elevated ridge).
  • Stage 3 – extraretinal fibro-vascular proliferation into vitreous.
  • Stage 4 – partial retinal detachment.
  • Stage 5 – total retinal detachment.
• Plus disease – dilated, tortuous posterior pole vessels (particularly optic-disk vessels) and is a harbinger of rapid progression.

Screening Protocols

• All infants with birth weight <1500\ \text{g} or gestational age $\le 30$ weeks require screening.
• Consider screening larger/older infants with high oxygen/ventilator needs or unstable courses.
• First exam: at corrected age $31$ weeks or $4$ weeks chronologic age – whichever is later.
• Follow-up interval: $1{-}3$ weeks, tailored to initial findings.

Management

• Laser diode ablation – circumferential treatment of avascular peripheral retina to diminish VEGF production.
• Pharmacologic anti-VEGF (e.g.
  • Bevacizumab – monoclonal antibody injected intra-vitreally).
  • Risks: persistent peripheral avascular retina, recurrence, and progression to detachment.

Prognosis and Sequelae

• Fewer than $10\%$ progress to therapy-requiring disease.
• Risk factors for progression: zone 1 involvement, plus disease, rapid advance, or stage 3 spanning >9 clock hours.
• Mild, spontaneously regressed ROP (stage 1–2, no plus): higher prevalence of myopia, strabismus, amblyopia.
• Severe disease survivors: severe myopia and glaucoma are common.

Bronchopulmonary Dysplasia (BPD)

Definition

Chronic lung disease of infancy marked by ongoing pulmonary inflammation, arrested lung development, and need for supplemental oxygen or mechanical ventilation $\ge 28$ days.

Contributory Factors (Table 10-1)

• Prematurity
• Ventilator injury
• Oxygen toxicity
• Fetal/neonatal inflammatory response
• Patent ductus arteriosus (PDA)
• Fluid balance anomalies
• Sub-optimal nutrition

Etiologic Details

Prematurity

• Infants delivered between $23{-}32$ weeks possess surfactant-deficient, structurally immature lungs.

Ventilator Injury

• High inspiratory pressures and high $FiO_2$ → barotrauma, volutrauma, atelectotrauma.
• Damage to alveolar–capillary membrane → proteinaceous leak, surfactant inactivation.

Oxygen Toxicity

• Higher target saturations escalate oxygen dependency at $36$ weeks, chronic disease exacerbations, and readmissions at $3$ months corrected age.

Inflammatory Cascade

• Fetal inflammatory response syndrome and elevated intra-amniotic/tracheal cytokines correlate strongly with BPD.
• Microvascular leakage → plasma flooding airspaces → surfactant inactivation → perpetuated inflammation.

Patent Ductus Arteriosus

• Occurs inversely with gestational age; augments respiratory support requirements and is associated (though not causative) with BPD.

Fluid & Electrolyte Maintenance

• Excess fluid/Na⁺ retention and PDA aggravate pulmonary edema and respiratory support needs.

Nutrition

• High caloric demands with low reserves; vitamin A deficiency specifically linked.

Diagnostic Criteria

• Combination of clinical course, radiography, and sustained O₂ need.
• NIH: oxygen requirement $\ge 28$ days and at $36$ weeks post-menstrual age.
• “New BPD” phenotype: less-severe course, diffuse hazy radiograph.

Radiographic Hallmarks

• Hyperinflated lungs (normal AP diameter on lateral).
• Diffuse haziness from interstitial fluid.
• “Spongy” appearance.

Management Principles

• Prevention prioritized: gentle ventilation strategies, judicious oxygen, non-invasive support when feasible.
• Once established, therapy is supportive:
  • Lung-protective ventilation.
  • Optimal calories/protein, vitamin A supplementation.

Complications & Long-Term Outcomes

• Disease often ameliorates with age but leaves residual issues.
• Pulmonary artery hypertension, structural lung abnormalities, airway hyper-reactivity, tracheomalacia, and glottic/sub-glottic injury.
• Up to $50\%$ are rehospitalized within first $2$ years, chiefly due to viral lower-respiratory infections.
• Increased ED visits, systemic steroid and antibiotic use, and protracted home respiratory support (nasal cannula to chronic ventilation).

Necrotizing Enterocolitis (NEC)

Definition

Acute, primarily prematurity-associated condition whereby segments of intestinal tissue undergo ischemic necrosis.

Incidence & Predilection

• Strongly correlated with low gestational age <28 weeks and low birth weight, yet also seen in term neonates with asphyxia or polycythemia.
• Severity frequently necessitates surgical resection of necrotic bowel.

Pathogenesis & Risk Factors

• Immature mucosal barrier coupled with immunologic immaturity.
• Perinatal stressors: polycythemia, birth asphyxia, exchange transfusion.

Clinical Manifestations

• Gastrointestinal: vomiting, abdominal tenderness/distension, bloody stools, feeding intolerance.
• Systemic: apnea, temperature instability, lethargy, metabolic/respiratory acidosis.

Diagnostic Work-Up

Imaging

• Abdominal radiograph – LLDP preferred for free air detection.
• Hepatic ultrasound – portal venous gas is highly suggestive and may precede perforation.

Laboratory Tests

• CBC with differential – thrombocytopenia implies necrosis/sepsis.
• Coagulation profile, serum electrolytes, ABG.
• Blood & stool cultures to identify pathogens.

Management Algorithm

1. Discontinue enteral feeds immediately.
2. Gastric decompression via NG suction.
3. Broad-spectrum IV antibiotics.
4. Supportive care: IV fluids, oxygen or mechanical ventilation as required.
5. Surgical intervention when indicated:
   • Exploratory laparotomy with resection of necrotic segments.
   • Primary peritoneal drainage as temporizing measure in unstable neonates.

Integrated Ethical, Practical, and Prognostic Considerations

• Balancing oxygen delivery: Both ROP and BPD underscore the ethical tension between life-saving oxygen supplementation and oxygen-mediated tissue injury. Optimizing saturation targets demands individualized, evidence-based protocols.
• Multidisciplinary approach: Ophthalmology, neonatology, surgery, pulmonology, and nutrition services must co-manage these fragile patients.
• Preventive strategies (antenatal steroids, gentle ventilation, judicious fluid/oxygen administration, early human milk feeding for NEC prophylaxis) remain the cornerstone, reflecting the axiom that avoidance of initial injury yields the best outcomes.

Key Numerical & Formulaic References

• Incidence ROP: $66\% \; (BW\le1250\,g)$; $90\% \; (BW\le750\,g)$.
• Screening age: $\text{first exam}=\max(31\,wks\;PMA,\;4\,wks\;chronologic)$.
• BPD definition: $O_2 \;use \ge 28\,days$ and evaluation at $36\,wks\;PMA$.
• Rehospitalization risk in BPD: $\approx 50\%$ within $2$ years.